Participate in this year's Eastbridge/BenefitsPRO survey to share your input and hear from other brokers on these questions and more. The results will be featured online in May!
An increase in costs amid lower payments from insurance plans makes it harder for small hospitals to fund large capital improvement projects, as hospital closures are reverting to pre-pandemic rates.
At the 42nd annual event for investors, pharma executives and biotech innovators, the spotlight was on AI, the new GLP-1 class of weight loss drugs, non-profit hospitals and treatment for autoimmune disease.
A look at new legal battles and drug regulations, including the administration's new initiatives to reduce drug costs and next steps in the FTC's attempt to address improperly listed patents in the FDA's Orange Book.
HSAs have become one of the most popular tools to manage health care and retirement spending but its evolution to becoming a popular benefit offering has been decades in the making.